Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02638909 |
| Title | Study of Oral Ceritinib in Patients With ALK-Activated Gastrointestinal Malignancies |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Criterium, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | United States | Details | |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | United States | Details | |
| Yale University, Yale Cancer Center | New Haven | Connecticut | 06520 | United States | Details | |
| Laura & Isaac Permutter Cancer Center at NYU Langone | New York | New York | 10016 | United States | Details | |
| The Ohio State University, James Cancer Hospital | Columbus | Ohio | 43210 | United States | Details | |
| Swedish Cancer Institute | Seattle | Washington | 98104 | United States | Details |